(Q34282241)

1 August 2017

1 reference

title

Mechanisms of resistance to cisplatin. (English)

1 reference

1 August 2017

1 reference

M Kartalou

1

1 reference

1 August 2017

J M Essigmann

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

478

1 reference

1 August 2017

issue

1-2

1 reference

1 August 2017

page(s)

23-43

1 reference

Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II).

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Studies on mutagenesis and repair induced by platinum analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HeLa Cells Treated with Cisplatin at Its Mean Lethal Concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Interactions between mammalian cell DNA and inorganic platinum compounds. II. Interstrand cross-linking of isolated and cellular DNA by platinum(IV) compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The measurement of cisplatin-DNA adduct levels in testicular cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Interstrand cross-links and sequence specificity in the reaction of cis-dichloro(ethylenediamine)platinum(II) with DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Effect of serum on inhibition of DNA synthesis in leukemia cells by cis- and trans-(Pt (NH3) 2C1(2)).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

DNA Adducts of cis-Diamminedichloroplatinum(II) and Its Trans Isomer Inhibit RNA Polymerase II Differentially in Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cellular accumulation of the anticancer agent cisplatin: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Modulation ofcis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Decreased cisplatin uptake by resistant L1210 leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Effect of hyperthermia on intracellular drug accumulation and chemosensitivity in drug-sensitive and drug-resistant P388 leukaemia cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Modulation of cis-dichlorodiammineplatinum(II)-induced cytotoxicity by benzaldehyde derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Protection from cis-dichlorodiammineplatinum-induced cell inactivation by aldehydes involves cell membrane amino groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Reduction of cis-dichlorodiammineplatinum-induced cell inactivation by benzaldehyde.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Active efflux system for cisplatin in cisplatin-resistant human KB cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The ATP-dependent glutathione S-conjugate export pump

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cellular and molecular determinants of cisplatin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Overexpression of metallothionein confers resistance to anticancer drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Tumours from a cell strain with a high content of metallothionein show enhanced resistance against cis-dichlorodiammineplatinum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Metallothionein levels in ovarian tumours before and after chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Role of metallothionein in cisplatin sensitivity of germ-cell tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Do metallothioneins affect the response to treatment in testis cancers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Influence of the proto-oncogene c-fos on cisplatin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Modulation of excision repair cross complementation group 1 (ERCC-1) mRNA expression by pharmacological agents in human ovarian carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Characterization of carboplatin-resistant sublines derived from human larynx carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Modulation of cytotoxicity of chemotherapeutic drugs by activated H-ras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Activated ras oncogene and specifically acquired resistance to cisplatin in human mammary epithelial cells: induction of DNA cross-links and their repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

ras mutation and platinum resistance in human ovarian carcinomas in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Determination of cell fate by c-Abl activation in the response to DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

New p73 variants with altered C-terminal structures have varied transcriptional activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Diverse functions of JNK signaling and c-Jun in stress response and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Lack of c-Jun activity increases survival to cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The actual incision determines the efficiency of repair of cisplatin-damaged DNA by the Escherichia coli UvrABC endonuclease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Human nucleotide excision repair in vitro: repair of pyrimidine dimers, psoralen and cisplatin adducts by HeLa cell-free extract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Multiple pathways of recombination define cellular responses to cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cloning, structural characterization, and chromosomal localization of the human orthologue of Saccharomyces cerevisiae MSH5 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cloning and characterization of the human and Caenorhabditis elegans homologs of the Saccharomyces cerevisiae MSH5 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cloning and expression analysis of a meiosis-specific MutS homolog: the human MSH4 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Repair of cisplatin-DNA adducts by protein extracts from human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Enhanced DNA repair and resistance to cisplatin in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

DNA repair capacity and cisplatin sensitivity of human testis tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Fork-like DNA templates support bypass replication of lesions that block DNA synthesis on single-stranded templates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

DNA polymerase beta bypasses in vitro a single d(GpG)-cisplatin adduct placed on codon 13 of the HRAS gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

The Efficiency and Fidelity of Translesion Synthesis past Cisplatin and Oxaliplatin GpG Adducts by Human DNA Polymerase β

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Overexpression of bax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Overexpression of the Bcl-2 Protein Increases the Half-life of p21Bax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Apoptosis in cancer therapy: crossing the threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

G(1) phase-dependent expression of bcl-2 mRNA and protein correlates with chemoresistance of human cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Synergistic enhancement of resistance to cisplatin in human bladder cancer cells by overexpression of mutant-type p53 and Bcl-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Acquired multicellular-mediated resistance to alkylating agents in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Apoptosis and c-jun induction by cisplatin in a human melanoma cell line and a drug-resistant daughter cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2801%2900141-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0027-5107(01)00141-5

1 reference

1 August 2017

1 reference